OK-432 for carcinoma in situ

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 4 registered trials.

Why this status

  1. 18 Mar 2026: Trial registered, NCT07480356
  2. 29 May 2026: Trial started, NCT07480356

The trials

NCT05085977: Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1a)

State
Completed
Phase
Phase 1
People
12 taking part
Started
10 Mar 2022
Primary completion
3 Sep 2024
Arms
TARA-002
Results
None posted
  1. 20 Oct 2021: Trial registered
  2. 10 Mar 2022: Trial started
  3. 30 Oct 2024: Trial completed

NCT05085990: Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1b)

State
Completed
Phase
Phase 1
People
10 taking part
Started
8 May 2023
Primary completion
12 Sep 2024
Arms
TARA-002
Results
None posted
  1. 20 Oct 2021: Trial registered
  2. 8 May 2023: Trial started
  3. 12 Sep 2024: Trial completed

NCT05951179: Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

State
Under way
Phase
Phase 2
People
131 planned
Started
15 Sep 2023
Primary completion
Oct 2031
Arms
TARA-002
Results
None posted
  1. 18 Jul 2023: Trial registered
  2. 15 Sep 2023: Trial started

NCT07480356: Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

State
Under way
Phase
Phase 3
People
284 planned
Started
29 May 2026
Primary completion
Apr 2028
Arms
TARA-002 (Arm A)
Results
None posted
  1. 18 Mar 2026: Trial registered
  2. 29 May 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Also known as Picibanil.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.